A Phase I/II, Randomized, Placebo-controlled Comparative study to evaluate the Safety and Potential Efficacy of Intravenous Infusion of Umbilical Cord Tissue (UC) derived Mesenchymal Stem Cells (MSCs) Versus Bone Marrow (BM) derived MSCs to evaluate cytokine suppression in patients with chronic inflammation due to Metabolic Syndrome. The CERES Trial.
Investigator: Joshua Hare
Institutional Protocol #: 20170095
National Clinical Trials Identifier: NCT03059355
Therapeutic Area: Other
Phase: Phase I/II
Enrolling Since: 12/13/2017